Surgical and Infection Control Devices Market By Product Type (Surgical Devices, Infection Control Devices), Application (General Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Plastic Surgery), End-user (Hospitals, Ambulatory Surgical Centers, Clinics), & Region for 2024-2031

Surgical and Infection Control Devices Market Valuation – 2024-2031

In 2024, the surgical and infection control devices market size was estimated at USD 221.83 Billion, with a projected increase to USD 339.78 Billion by 2031, reflecting a CAGR of 5.6% from 2024 to 2031. This growth is driven by various factors, including technological advancements, increasing surgical procedures, and rising awareness of infection control measures. Throughout the forecast period, steady expansion is anticipated, underpinned by the continuous development of surgical and infection control devices.

Surgical and Infection Control Devices MarketDefinition/Overview

Surgical and infection control devices encompass a vast array of equipment used to perform surgeries and prevent the spread of infections. Surgical devices include scalpels, laparoscopic instruments, and even robotic systems, facilitating precise and minimally invasive procedures for faster recovery.

Infection control devices, like disinfectants, sterilization equipment, and personal protective equipment, are employed to safeguard patients and healthcare workers from harmful pathogens. These devices offer significant advantages. Surgical instruments enable more effective procedures with minimal tissue disruption, while infection control measures create a safer environment, reducing hospital-acquired infections and improving patient outcomes.

What Significant Role Have Advancements in Technology Played in Driving the Growth of the Surgical and Infection Control Devices Market?

Technological advancements are playing a pivotal role, with continuous innovations leading to the development of more advanced and efficient surgical and infection control devices. These advancements are enhancing the efficacy, safety, and precision of surgical procedures, thus contributing to market growth.

Moreover, the increasing prevalence of chronic diseases and the growing geriatric population are fueling the demand for surgical interventions, consequently boosting the adoption of surgical devices. Another significant driver is the rising awareness of infection control measures among healthcare professionals and patients.

With the increasing incidence of hospital-acquired infections (HAIs) and surgical site infections (SSIs), there is a heightened focus on implementing stringent infection control protocols. This has led to a surge in the demand for infection control devices such as sterilization equipment, disinfectants, and personal protective equipment (PPE). Regulatory initiatives aimed at ensuring patient safety and maintaining high standards of infection control are influencing market dynamics.

The expanding healthcare infrastructure, particularly in emerging economies, is providing lucrative growth opportunities for the surgical and infection control devices market. Rapid urbanization, increasing healthcare expenditure, and improving access to healthcare services are driving the adoption of advanced medical technologies, including surgical and infection control devices.

Furthermore, the growing trend of outpatient surgeries and the establishment of ambulatory surgical centers (ASCs) are contributing to market expansion by catering to the rising demand for minimally invasive procedures. The market is also benefiting from the growing emphasis on preventive healthcare measures and the promotion of good hygiene practices. Healthcare organizations and governments worldwide are implementing public health campaigns and initiatives to educate the population about the importance of infection prevention and control. This heightened awareness is driving the adoption of infection control devices and encouraging healthcare facilities to invest in state-of-the-art equipment to ensure patient safety and minimize the risk of infections. These factors collectively contribute to the continued expansion of the market, with opportunities for further growth expected in the foreseeable future.

What Factors are Plummeting Sales of the Surgical and Infection Control Devices Market?

Several factors are contributing to the plummeting sales of the surgical and infection control devices market. One significant factor is the emergence of alternative treatment options and therapies, which are diverting attention and resources away from traditional surgical interventions. These alternatives offer less invasive approaches and may be perceived as safer or more cost-effective by patients and healthcare providers alike. Consequently, the demand for surgical devices is diminishing as healthcare preferences shift towards non-surgical solutions. Economic downturns and budget constraints in healthcare systems worldwide are exerting pressure on hospitals and medical facilities to reduce expenditures. This has led to a cautious approach towards purchasing new medical equipment, including surgical and infection control devices. Additionally, reimbursement challenges and changes in healthcare policies are contributing to uncertainty in the market, further impeding sales growth.

The increasing trend towards outpatient care and minimally invasive procedures is impacting the demand for traditional surgical devices. Outpatient surgeries offer cost savings and shorter recovery times, making them preferable for patients and healthcare providers. Consequently, there is a reduced need for complex surgical equipment traditionally used in inpatient settings, leading to a decline in sales. Public health initiatives and awareness campaigns are encouraging individuals to adopt healthier lifestyles and practices to prevent diseases and infections. This proactive approach to healthcare may reduce the need for surgical interventions and infection control devices, thereby contributing to declining sales in the market.

Furthermore, the regulatory scrutiny and compliance requirements in the healthcare sector are increasing, posing challenges for manufacturers of surgical and infection control devices. Strict regulations regarding product safety, efficacy, and quality assurance necessitate significant investments in research, development, and regulatory compliance, which may deter market players and hinder sales growth.

Category-Wise Acumens

Which Product Type Category Holds the Dominant Market Share in the Surgical and Infection Control Devices Market?

In the surgical and infection control devices market, the dominant market share is held by surgical devices. A wide range of instruments and equipment used in various surgical procedures across different medical specialties is encompassed by surgical devices. A crucial role is played by these devices in facilitating surgical interventions, enhancing procedural efficiency, and ensuring optimal patient outcomes. With the rising prevalence of chronic diseases, advancements in medical technology, and expanding healthcare infrastructure, there has been a significant uptick in the demand for surgical interventions. The adoption of surgical devices, including instruments, equipment, and consumables, is driven by this heightened demand, thereby consolidating the market share of this product category.

Additionally, technological advancements and innovations in surgical devices are bolstering their market position. More advanced and specialized surgical instruments and equipment have been introduced as a result of continuous research and development efforts. These innovations focus on improving surgical precision, minimizing invasiveness, and enhancing patient safety, thereby increasing the appeal and adoption of surgical devices among healthcare providers.

The demand for specialized surgical devices tailored for these procedures is driven by the growing trend towards minimally invasive surgeries (MIS). Several advantages over traditional open surgeries, including reduced post-operative pain, shorter hospital stays, and faster recovery times, are offered by minimally invasive techniques. Consequently, increased utilization of minimally invasive surgical devices and contribution to the dominant market share of surgical devices has led to a growing preference for MIS among both patients and surgeons.

Furthermore, a higher volume of surgical interventions is necessitated by the expanding geriatric population and the increasing prevalence of age-related conditions. A critical role in addressing the healthcare needs of elderly patients, including those undergoing joint replacements, cardiac surgeries, and other procedures commonly performed in this demographic group, is played by surgical devices. As the elderly population continues to grow globally, the demand for surgical devices is expected to remain robust, further solidifying their dominant market share.

Will the Orthopedic Surgery Segment Turn into an Epicenter of Growth in the Surgical and Infection Control Devices Market?

The demand for orthopedic surgical interventions is being driven by the escalating prevalence of musculoskeletal disorders and injuries worldwide. An aging population and increasing incidence of conditions such as osteoarthritis, fractures, and sports injuries are observed, leading to a growing need for orthopedic surgeries to restore mobility, alleviate pain, and improve quality of life. It is expected that this rising demand for orthopedic procedures will fuel the adoption of surgical and infection control devices tailored for orthopedic surgery.

Additionally, innovations such as minimally invasive surgery, computer-assisted navigation, and 3D printing are enabling surgeons to perform more precise, customized, and effective interventions. As orthopedic surgeons embrace these advancements to enhance patient outcomes and surgical efficiency, there is a corresponding increase in the utilization of specialized orthopedic devices, including implants, instruments, and infection control solutions.

Stringent requirements for the safety, efficacy, and quality assurance of orthopedic devices are being imposed by regulatory agencies and healthcare authorities. Compliance with these regulations necessitates continuous innovation, research, and development by manufacturers, driving investment in advanced orthopedic surgical and infection control technologies. Moreover, the role of orthopedic surgery as a growth epicenter in the surgical and infection control devices market is further amplified by the expanding application of orthopedic surgery across diverse patient populations and medical specialties. Not only traditional joint replacements but also spine surgery, trauma surgery, sports medicine, and orthobiologics are encompassed by orthopedic procedures. This broadening scope of orthopedic interventions increases the demand for a comprehensive range of surgical and infection control devices tailored to specific orthopedic applications and patient needs. Therefore, the orthopedic surgery segment is poised to emerge as a central driver of growth in the surgical and infection control devices market.

Gain Access to Surgical and Infection Control Devices Market Report Methodology

Country/Region Wise Acumens

Could North America Drive an Increase in Sales within the Surgical and Infection Control Devices Market?

Advanced healthcare infrastructure and significant investments in medical technologies characterize the region, positioning North America as a key market for surgical and infection control devices. Stringent regulatory standards and a strong emphasis on patient safety in North America necessitate the continuous development and adoption of advanced medical devices, including those used in surgical procedures and infection control. Compliance with these regulations requires manufacturers to invest in research, development, and quality assurance measures, thereby driving sales growth within the market.

Moreover, the rising demand for surgical interventions is contributed to by the increasing prevalence of chronic diseases and the aging population in North America. The incidence of conditions such as cardiovascular diseases, orthopedic disorders, and cancer is observed to escalate, leading to a corresponding increase in the need for surgical procedures and related medical devices. This trend fuels the demand for surgical and infection control devices, potentially leading to an increase in sales.

Sales growth within the surgical and infection control devices market in North America is significantly driven by technological advancements and innovations. The region is known for its robust healthcare research and development ecosystem, leading to the continuous introduction of cutting-edge medical technologies. Advancements such as robotic-assisted surgery, minimally invasive techniques, and advanced sterilization methods are observed to enhance the efficacy, precision, and safety of surgical procedures. As these innovations are embraced by healthcare providers in North America to improve patient outcomes and operational efficiency, there is a corresponding surge in the adoption of associated medical devices, further driving sales within the market. In conclusion, North America’s advanced healthcare infrastructure, regulatory standards, demographic trends, and technological innovations, collectively position the region to drive an increase in sales within the surgical and infection control devices market.

Will the Sales of the Surgical and Infection Control Devices Market fare well in Asia Pacific?

Rapid economic growth and development in Asia Pacific lead to an expansion of healthcare infrastructure and an increase in healthcare expenditure. Consequently, significant growth opportunities are presented for the surgical and infection control devices market in the region. Additionally, the demand for surgical interventions and infection control measures is fueled by the increasing prevalence of chronic diseases and infectious conditions in Asia Pacific, thereby driving sales within the market. A surge in the adoption of advanced medical technologies, including minimally invasive surgical techniques, robotic-assisted surgery, and state-of-the-art sterilization equipment, is being witnessed in the region. The efficacy, safety, and precision of surgical procedures are enhanced by these innovations, contributing to the growth of the market and fostering a favorable environment for sales expansion.

Furthermore, heightened attention towards implementing stringent infection control protocols and investing in infection control devices, such as sterilization equipment, disinfectants, and personal protective equipment, is observed due to the increasing incidence of hospital-acquired infections and surgical site infections. This heightened awareness stimulates the demand for infection control solutions, consequently boosting sales within the market. Lucrative growth opportunities for the surgical and infection control devices market are provided by the expanding healthcare infrastructure and rising healthcare expenditure in emerging economies across Asia Pacific. Market expansion in the region is further contributed to by rapid urbanization, increasing access to healthcare services, and a growing emphasis on preventive healthcare measures.

Moreover, the market dynamics are influenced by regulatory initiatives aimed at ensuring patient safety and maintaining high standards of infection control, fostering a conducive environment for sales growth in Asia Pacific. Overall, it is expected that the sales of the Surgical and Infection Control Devices Market will fare well in Asia Pacific, driven by factors such as economic growth, technological advancements, increasing prevalence of diseases, growing awareness of infection control measures, expanding healthcare infrastructure, and regulatory initiatives.

Competitive Landscape

Analyzing the competitive landscape of the surgical and infection control devices market is crucial for gaining insights into the industry’s dynamics. This research aims to delve into the competitive landscape, focusing on key players, market trends, innovations, and strategies. By conducting this analysis, valuable insights will be provided to industry stakeholders, assisting them in navigating the competitive environment adeptly and seizing emerging opportunities. Understanding the competitive landscape will enable stakeholders to make informed decisions, align with market trends, and formulate strategies to strengthen their market position and competitiveness in the surgical and infection control devices market.

Some of the prominent players operating in the surgical and infection control devices market include

• 3M, BD
• Belimed
• Biomerieux
• Getinge
• Kimberly-Clark
• Sotera Health
• Ansell Limited
• Steris
• Lac-Mac
• Pacon Manufacturing
• American Polyfilm

Latest Developments

• In November 2020, the launch of AppliFlex ST, a customizable single-use bioreactor optimizing processes and reducing labor hours in the lab, was announced by Applicon Biotechnology, a division of Getinge.
• In January 2021, the acquisition of Cantel Medical, a global provider of products preventing infection and providing services to dialysis, dental, endoscopy, and life sciences customers, was announced by Steris.

Report Scope

Surgical and Infection Control Devices Market, By Category

Product Type

• Surgical Devices
• Surgical Sutures and Staples
• Handheld Surgical Instruments
• Electrosurgical Devices
• Surgical Power Tools
• Surgical Suction Devices
• Infection Control Devices
• Sterilization Equipment
• Disinfectants
• Personal Protective Equipment

Application

• General Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurosurgery
• Plastic Surgery

End-User

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Research Methodology of Market Research